Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jeff Barrett appointed CTTV's founding director

This article was originally published in Scrip

Executive Summary

Dr Jeffrey Barrett has been appointed the founding director of the Centre for Therapeutic Target Validation (CTTV), a public-private partnership between GlaxoSmithKline, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute (scripintelligence.com, 27 March 2014). Dr Barrett has been involved in the CTTV since its inception in 2014 and will begin his new role on 1 May 2015.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC027960

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel